These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 35092335)

  • 1. Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19?
    Terziroli Beretta-Piccoli B; Lleo A
    Liver Int; 2022 Feb; 42(2):274-276. PubMed ID: 35092335
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune hepatitis triggered by COVID-19: A report of two cases.
    Kabaçam G; Wahlin S; Efe C
    Liver Int; 2021 Oct; 41(10):2527-2528. PubMed ID: 34478591
    [No Abstract]   [Full Text] [Related]  

  • 3. Behaviors, symptoms, and outcomes of North American patients with autoimmune hepatitis during the COVID-19 pandemic.
    Vuppalanchi V; Gelow K; Green K; Vuppalanchi R; Lammert C
    J Investig Med; 2021 Dec; 69(8):1426-1433. PubMed ID: 34315800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use.
    Ng AC
    Hepatol Commun; 2021 Oct; 5(10):1801-1802. PubMed ID: 34222740
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of patients with autoimmune liver disease during COVID-19 pandemic.
    Lleo A; Invernizzi P; Lohse AW; Aghemo A; Carbone M
    J Hepatol; 2020 Aug; 73(2):453-455. PubMed ID: 32283134
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the Editor: Reply to Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use.
    Efe C; Wahlin S
    Hepatol Commun; 2022 Nov; 6(11):3272. PubMed ID: 34558846
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 in Immunocompromised Patients: A Systematic Review.
    Stainer A; Amati F; Suigo G; Simonetta E; Gramegna A; Voza A; Aliberti S
    Semin Respir Crit Care Med; 2021 Dec; 42(6):839-858. PubMed ID: 34918325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality.
    Rocco A; Sgamato C; Compare D; Nardone G
    J Hepatol; 2021 Sep; 75(3):728-729. PubMed ID: 34116081
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: immunosuppression and SARS-CoV-2 vaccination-where do we stand?
    Ananthakrishnan AN
    Aliment Pharmacol Ther; 2023 Jan; 57(1):163-164. PubMed ID: 36480719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2-specific immunity in immunosuppressed COVID-19 convalescents with autoimmune hepatitis.
    Kirchner T; Jaeckel E; Falk CS; Eiz-Vesper B; Taubert R
    J Hepatol; 2021 Dec; 75(6):1506-1509. PubMed ID: 34284030
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune hepatitis triggered by COVID-19.
    Montón Rodríguez C; Navarro Cortés P; Lluch García P; Mínguez Pérez M
    Rev Esp Enferm Dig; 2022 Jan; 114(1):64-65. PubMed ID: 34015933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?".
    Capecchi PL; Lazzerini PE; Brillanti S
    J Hepatol; 2021 Oct; 75(4):994-995. PubMed ID: 33964372
    [No Abstract]   [Full Text] [Related]  

  • 13. The mRNA COVID-19 vaccine - A rare trigger of autoimmune hepatitis?
    McShane C; Kiat C; Rigby J; Crosbie Ó
    J Hepatol; 2021 Nov; 75(5):1252-1254. PubMed ID: 34245804
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"".
    Bril F; Fettig DM
    J Hepatol; 2021 Oct; 75(4):996-997. PubMed ID: 34146650
    [No Abstract]   [Full Text] [Related]  

  • 15. Another case of autoimmune hepatitis after SARS-CoV-2 vaccination - still casualty?
    Londoño MC; Gratacós-Ginès J; Sáez-Peñataro J
    J Hepatol; 2021 Nov; 75(5):1248-1249. PubMed ID: 34129886
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?
    Tan CK; Wong YJ; Wang LM; Ang TL; Kumar R
    J Hepatol; 2021 Nov; 75(5):1250-1252. PubMed ID: 34153398
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune Hepatitis Associated with COVID-19 Infection - A Diagnostic and Therapeutic Dilemma.
    Rajendiran G; Cowman B; Erickson K; Oliver T; Manatsathit W
    S D Med; 2020 Nov; 73(11):528-532. PubMed ID: 33684272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis triggered by COVID-19.
    Hong JK; Chopra S; Kahn JA; Kim B; Khemichian S
    Intern Med J; 2021 Jul; 51(7):1182-1183. PubMed ID: 34278694
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: One or even several swallows do not make a summer.
    Bril F
    J Hepatol; 2021 Nov; 75(5):1256-1257. PubMed ID: 34384822
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation.
    Wu H; He P; Ren Y; Xiao S; Wang W; Liu Z; Li H; Wang Z; Zhang D; Cai J; Zhou X; Jiang D; Fei X; Zhao L; Zhang H; Liu Z; Chen R; Li W; Wang C; Zhang S; Qin J; Nashan B; Sun C
    Nat Commun; 2022 Jan; 13(1):269. PubMed ID: 35022412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.